First Genetically Edited Cows Arrive at UC Davis
By Edward Ortiz,
Sacramento Bee
| 12. 20. 2015
Untitled Document
The two calves that grace a muddy pen on the UC Davis campus will never grow horns typical of their breed. Instead, they’ll always sport soft hair on the parts of their heads where hard mounds normally emerge.
Named Spotigy and Buri, the calves were designed in a petri dish at a Minnesota-based genetics lab, with the goal of making them easier to pack into pens and trucks without the nuisance of their horns taking up valuable space. Their offspring may also lack horns, and generations of hornless cows could follow, potentially saving the dairy and cattle industry millions of dollars, said Alison Van Eenennaam, a geneticist at UC Davis’ College of Agriculture and Environmental Sciences who worked with the Minnesota lab Recombinetics.
This first-of-a-kind result of a process called genetic editing is a test run that’s expected to deeply impact the cattle and dairy industry and the entire food supply, Van Eenennaam said. It’s also part of a flurry of research looking at how to make cattle easier to maintain, transport and turned into food. The research...
Related Articles
By Mike McIntire, The New York Times | 01.24.2026
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...